NoblePath CRO — Clinical Trial Partner in Türkiye

Why Choose NoblePath

Why Sponsors Choose NoblePath

Therapeutic Breadth

Six therapeutic areas under one CRO roof — oncology, cardiovascular, CNS, endocrine metabolic disorders, infectious disease, and internal medicine & immunology. No hand-offs, no gaps.

48-Hour Feasibility

Site-verified, KOL-driven feasibility assessments delivered within 48 hours — realistic enrollment projections, not optimistic assumptions.

On-Site Ethics Committee Access

Network sites with institutional Ethics Committees enable parallel TITCK and EC submissions — reducing review timelines from 6–8 weeks to 2–3 weeks at top sites.

At a Glance

Capabilities Snapshot

LocationAnkara, Türkiye

Trial PhasesPhase I, II, III & IV

Therapeutic AreasOncology · Cardiovascular · CNS · Endocrine Metabolic · Infectious Disease · Internal Medicine & Immunology

RegulatoryTITCK approved · ICH-GCP aligned · KVKK & GDPR compliant

Feasibility Turnaround≤ 48 hours

Site NetworkHacettepe University Oncology Hospital + Ankara Bilkent City Hospital CRC + additional academic centers

Patient AccessLarge, treatment-naïve patient populations across therapeutic areas

GovernanceEthics-first — 10+ published company policies including Anti-Bribery, Sustainability, and Human Rights

Therapeutic Expertise

Therapeutic Focus

Oncology

Solid tumors and hematologic malignancies — Phase I through IV

Cardiovascular

Acute and chronic cardiovascular disease programs

Central Nervous System

Neurodegenerative and neuroimmunological disorders

Endocrine Metabolic Disorders

Diabetes, obesity, and endocrine-related metabolic conditions

Infectious Disease

Antimicrobial, antiviral, and vaccine development programs

Internal Medicine & Immunology

Autoimmune, inflammatory, and immune-mediated diseases

Our Network

Featured Sites & Principal Investigators

NoblePath's network includes Türkiye's most experienced academic medical centers — with multidisciplinary investigators, Phase 1 infrastructure, and institutional Ethics Committees that accelerate study start-up.

Hacettepe University Oncology Hospital

Ankara, Türkiye — First academic center in Türkiye accredited by Joint Commission International (JCI). Home to Türkiye's only Phase I unit dedicated to oncology trials.

JCI

264

active clinical trials

Only

oncology Phase I unit in Türkiye

25000

sample biobank capacity

264 active clinical trials across the institution
109 active Medical Oncology trials · 526 oncology patients actively followed
13 Medical Oncology faculty · 10 fellows in training
117 inpatient beds (Medical Oncology, Oncology ICU, Bone Marrow Transplantation, Pediatric Oncology)
Phase I Unit: 4 private rooms on Level 5; Oncology ICU one floor below for rapid escalation
Cancer Registry with linked Biobank (25,000-sample storage capacity)

2 PET-CTCyberknifeNovalisZAP-X3 LINACs

Investigators

Prof. Dr. Mustafa Erman — Phase I Lead · Lung & GU

Prof. Dr. Ömer Dizdar — Phase I · GI & Melanoma

Prof. Dr. Sercan Aksoy — Phase I · Breast & H&N

Prof. Dr. Zafer Arık — Phase I · Gynecological

Asst. Prof. Dr. Burak Yasin Aktaş — Phase I · Lung & GU

Assoc. Prof. Dr. Serkan Akın — Hematological Malignancies

Assoc. Prof. Dr. Deniz Can Güven — Breast, H&N, GI, Melanoma

Ankara Bilkent City Hospital CRC

Ankara, Türkiye — One of Türkiye's largest hospital complexes. TITCK-certified Phase 1 Clinical Research Center, ICH and PIC/S member, GCP-certified.

TITCKICHPIC/SGCP

4050

inpatient beds

2–3 wk

Ethics Committee review

24

bed Phase 1 CRC

4,050 inpatient beds · 968 ICU beds · 583 polyclinics · 117 operating rooms
18,000+ healthcare professionals — including 400+ Professors, 300+ Associate Professors
2,500+ scientific research projects annually
Phase 1 CRC (est. Apr 2021, recertified Oct 2023): 1,310 m², 24 beds in 12 private rooms, 1 reserved ICU bed
Dedicated IMP storage (−20°C, 2–8°C, ambient) + lab storage (−80°C, −20°C, 2–8°C)
On-site Clinical Research Ethics Committee: 2–3 week review timeline
Two additional IRBs for non-interventional studies

Investigator Team

13 Principal Investigators — 8 Oncologists, 2 Hematologists, 1 Pediatric Neurologist, 1 Dermatologist

6 dedicated Site Coordinators

Additional network sites are available based on protocol requirements and therapeutic focus.

Full-Service Capabilities

What We Deliver

Clinical Trial Management

End-to-end trial oversight — protocol planning, vendor management, data monitoring, and sponsor reporting from IND to close-out.

Site Coordination

Dedicated on-site coordinators managing patient scheduling, ICF execution, case report forms, and regulatory documentation.

Site Management

Full site qualification, activation, and performance management — with risk-based monitoring and continuous quality oversight.

Equipment Supply & Calibrations

Clinical-grade equipment sourcing, calibration, and maintenance for trial sites — reducing start-up delays.

Regulatory Services

TITCK submission strategy, ethics committee navigation, IP import permits, SUSAR reporting, and end-to-end regulatory documentation.

The Process

How We Work With Sponsors

Step 01

Feasibility (≤ 48 hours)

Site-verified assessment of patient pool, competing trials, and enrollment risk — sponsor-ready output delivered within 48 hours.

Step 02

Regulatory Start-Up (~6–8 weeks)

Parallel TITCK and Ethics Committee submissions through institutional ECs, with end-to-end documentation management and IP import coordination.

Step 03

Site Activation & Monitoring

Project management, vendor and SMO oversight, risk-based monitoring, and continuous sponsor communication from first patient in to database lock.

Education & Training

NoblePath Academy

We believe better-trained site teams produce better trials. NoblePath Academy is our commitment to raising the standard of clinical research practice across Türkiye — open to coordinators, investigators, and regulatory professionals beyond our own organisation.

GCP Training

ICH E6(R2) Good Clinical Practice — foundational certification for all clinical research professionals operating under international standards.

Source Document Training

Best-practice training on source data integrity, contemporaneous recording, and audit-trail requirements for site teams.

Site Management Training

End-to-end site management methodology — qualification, activation, performance oversight, and close-out.

Site Coordination Training

Practical coordination skills for study coordinators — patient scheduling, ICF management, regulatory documentation, and sponsor communication.

When your trial activates at a NoblePath site, the coordination team has been trained to our standard — not just to the minimum.

Explore NoblePath Academy →

Your Clinical Research Partner in Türkiye